Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022

SELL
$51.49 - $81.64 $169,608 - $268,922
-3,294 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$60.03 - $76.49 $197,738 - $251,958
3,294 New
3,294 $251,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $909M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Hightower 6 M Holding, LLC Portfolio

Follow Hightower 6 M Holding, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hightower 6 M Holding, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hightower 6 M Holding, LLC with notifications on news.